Jan 08, 2017 “My vision is that additive technologies and processes will be more ubiquitous in healthcare and tremendous value, in the form of more efficient and effective health outcomes, will be realized through the customization of implants, medical devices, and tailored therapeutics.”
John Jaddou has 20+ year experience in senior corporate roles and management consulting and has worked on strategy formulation, new product development, portfolio optimization, business model innovation, and commercial development. He currently works as a management consultant and interim executive with companies in the medical device, high technology, industrial products, and advanced materials sectors. John also serves as a Research Scientist at MIT where he focuses on Additive Manufacturing / 3D Printing. John holds an MSc in Engineering from the University of Michigan and an MBA from Michigan Ross School of Business. John will be a speaker at #3DHEALS2017.
Q: What is your vision on the intersection of 3D Printing and healthcare?
A: My vision is that additive technologies and processes will be more ubiquitous in healthcare and tremendous value, in the form of more efficient and effective health outcomes, will be realized through the customization of implants, medical devices, and tailored therapeutics.
Q: What is the biggest potential impact you see 3D printing (or bioprinting) having on the healthcare industry?
A: I believe one of the biggest short term potential is the development and manufacturing of pharmaceuticals that are customized to the individual. A significant number of drugs do not work properly because of incorrect dosage and release profile.
Q: What challenges do you see arising in implementing 3D printing (or bioprinting) in healthcare sector in the next 5 years?
A: Current regulations and slow legislation may reduce the pace of adoption. The number of people working on bioprinting compared to conventional processes is limited. As such this could also limit adoption.
Q: Who inspires you the most in the 3D printing industry?
A: The people who are charting new territories with tissue and organ printing inspire me the most.
Q: What is the best business lesson you have learned?
A: To always keep learning and stretching my comfort zone.
Q: What is the biggest business risk you have taken?
A: Adopting unproven technology to accelerate the development of innovative products
Comments